Legal Issues

Court of Appeals Confirms Ruling That Generic Taxol Approval Should Be Withdrawn

Published in Cancer Weekly, February 12th, 2002

The Federal Court of Appeals for the District of Columbia confirmed that Ivax Corp.'s approval to market a generic version of Taxol should be withdrawn. In a ruling issued on January 11, the court let stand its prior order to the U.S. Food and Drug Administration (FDA) to withdraw the FDA approval previously granted to Ivax to market a generic equivalent of Taxol.

Ivax had requested the DC court to reconsider its prior ruling, which overturned for a second time a trial court ruling in favor of Ivax. The Appellate Court summarily denied the Ivax request for reconsideration of the Appellate Court ruling which found the FDA's approval for the Ivax generic product to be...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2002-02-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry